Overview

HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Hypothesis: In giant cell arteritis (GCA), a short initial treatment with anti-TNF may allow a faster decrease of steroids dosage and therefore avoid some of the adverse events of steroids.
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborator:
Abbott
Treatments:
Adalimumab